Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage

被引：0

作者：

Olivier Bousiges

Nathalie Philippi

Thomas Lavaux

Armand Perret-Liaudet

Ingolf Lachmann

Caroline Schaeffer-Agalède

Pierre Anthony

Anne Botzung

Lucie Rauch

Barbara Jung

Paulo Loureiro de Sousa

Catherine Demuynck

Catherine Martin-Hunyadi

Benjamin Cretin

Frédéric Blanc

机构：

[1] University Hospital of Strasbourg,Laboratory of Biochemistry and Molecular Biology

[2] University of Strasbourg,Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA)

[3] CNRS UMR7364,CM2R (Research and Resources Memory Centre), Geriatric Day Hospital and Neuropsychology Unit, Geriatrics Department

[4] University Hospitals of Strasbourg,Neurochemistry Laboratory, Biochemistry Department, Centre de Biologie et Pathologie Est

[5] University of Strasbourg and CNRS,BIORAN Team, Lyon Neuroscience Research Center, CNRS UMR 5292

[6] ICube Laboratory UMR 7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), INSERM U1028

[7] Team IMIS,Center for Memory Resources and Research, Hospices Civils de Lyon

[8] Hospices Civils de Lyon,Geriatrics Department

[9] Université de Lyon - Université Claude Bernard,undefined

[10] Charpennes Hospital,undefined

[11] Lyon 1 University,undefined

[12] AJ Roboscreen GmbH,undefined

[13] General Hospital Centre,undefined

[14] CM2R,undefined

[15] Geriatric Day Hospital,undefined

来源：

Alzheimer's Research & Therapy | / 12卷

关键词：

Dementia with Lewy bodies; Alzheimer’s disease; Prodromal; Dementia; Cerebrospinal fluid biomarkers; Total alpha-synuclein;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer's disease and dementia with Lewy bodies from the prodromal stage
Bousiges, Olivier
Philippi, Nathalie
Lavaux, Thomas
Perret-Liaudet, Armand
Lachmann, Ingolf
Schaeffer-Agalede, Caroline
Anthony, Pierre
Botzung, Anne
Rauch, Lucie
Jung, Barbara
de Sousa, Paulo Loureiro
Demuynck, Catherine
Martin-Hunyadi, Catherine
Cretin, Benjamin
Blanc, Frederic
ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
[2] Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical Practice
Lilamand, Matthieu
Clery, Josue
Vrillon, Agathe
Mouton-Liger, Francois
Cognat, Emmanuel
Gaubert, Sinead
Hourregue, Claire
Martinet, Matthieu
Dumurgier, Julien
Hugon, Jacques
Bouaziz-Amar, Elodie
Paquet, Claire
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
[3] Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies
Bousiges, Olivier
Cretin, Benjamin
Lavaux, Thomas
Philippi, Nathalie
Jung, Barbara
Hezard, Sylvie
Heitz, Camille
Demuynck, Catherine
Gabel, Aurelia
Martin-Hunyadi, Catherine
Blanc, Frederic
JOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (04) : 1069 - 1083
[4] Diagnostic value of cerebrospinal fluid alpha-synuclein in dementia with Lewy body
Bousiges, Olivier
Blanc, Frederic
GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2018, 16 (03): : 305 - 310
[5] Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies
Perra, Daniela
Bongianni, Matilde
Novi, Giovanni
Janes, Francesco
Bessi, Valentina
Capaldi, Stefano
Sacchetto, Luca
Tagliapietra, Matteo
Schenone, Guido
Morbelli, Silvia
Fiorini, Michele
Cattaruzza, Tatiana
Mazzon, Giulia
Orru, Christina D.
Catalan, Mauro
Polverino, Paola
Bernardini, Andrea
Pellitteri, Gaia
Valente, Mariarosa
Bertolotti, Claudio
Nacmias, Benedetta
Maggiore, Giandomenico
Cavallaro, Tiziana
Manganotti, Paolo
Gigli, Gianluigi
Monaco, Salvatore
Nobili, Flavio
Zanusso, Gianluigi
BRAIN COMMUNICATIONS, 2021, 3 (02)
[6] Alpha-synuclein in the Cerebrospinal Fluid Differentiates Synucleinopathies (Parkinson Disease, Dementia With Lewy Bodies, Multiple System Atrophy) From Alzheimer Disease
Tateno, Fuyuki
Sakakibara, Ryuji
Kawai, Takayuki
Kishi, Masahiko
Murano, Takeyoshi
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2012, 26 (03) : 213 - 216
[7] Diagnostic value of CSF chromogranin A to discriminate between Alzheimer's disease and dementia with Lewy bodies
Bousiges, Olivier
Lavaux, Thomas
Demuynck, Catherine
Schaeffer-Agalede, Caroline
Philippi, Nathalie
Muller, Candice
Cretin, Benjamin
Blanc, Frederic
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2024, 50 (01)
[8] The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies - A systematic review and meta-analysis
Lim, Xuxin
Yeo, Jing Ming
Green, Alison
Pal, Suvankar
PARKINSONISM & RELATED DISORDERS, 2013, 19 (10) : 851 - 858
[9] Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease
Beyer, Katrin
Humbert, Jordi
Ferrer, Anna
Lao, Jose I.
Carrato, Cristina
Lopez, Dolores
Ferrer, Isidro
Ariza, Aurelio
NEUROREPORT, 2006, 17 (12) : 1327 - 1330
[10] Investigating alpha-synuclein co-pathology in Alzheimer's disease bymeans of cerebrospinal fluid alpha-synuclein seed amplification assay
Bellomo, Giovanni
Toja, Andrea
Paoletti, Federico Paolini
Ma, Yihua
Farris, Carly M.
Gaetani, Lorenzo
Salvadori, Nicola
Chiasserini, Davide
LidiaWojdala, Anna
Concha-Marambio, Luis
Parnetti, Lucilla
ALZHEIMERS & DEMENTIA, 2024, 20 (04) : 2444 - 2452

← 1 2 3 4 5 →